Allison Gordon

Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma

A. Lesokhin, T. Hollmann, A. Markova, 2022, Leukemia & lymphoma.

Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes

C. Sigel, V. Rotemberg, M. Capanu, 2022, Cancer medicine.

Use of Asynchronous Interprofessional e-Consults in Cancer Patients During the COVID-19 Pandemic: Current and Future Role.

V. Rotemberg, J. Mones, N. Kurtansky, 2022, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

Management of immune-related cutaneous adverse events with dupilumab

M. Lacouture, Y. Janjigian, S. Dusza, 2023, Journal for ImmunoTherapy of Cancer.

Oncodermatology: Advancing the Science and Care of Cancer Patients and Survivors

M. Lacouture, M. Anadkat, A. Rossi, 2022, American Journal of Clinical Dermatology.

Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor–positive breast cancer.

S. Chandarlapaty, M. Robson, M. Lacouture, 2022, Journal of Clinical Oncology.